Adam R. Craig, President and CEO at CTI BIOPHARMA CORP (CTIC), bought 5,000 shares at $5.50 ($28K) on 2022-08-16, disclosed to the SEC on 2022-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CTIC | SELL | 2023-01-26 | $512K | — | Filing → |
| CTIC | SELL | 2023-01-03 | $1.2M | — | Filing → |
| CTIC | SELL | 2022-11-14 | $1.6M | — | Filing → |